Table 4 Adverse events with an incidence > 1
Adverse event, n (%) | Placebo (n = 208) | Formoterol 4.5 μg bid (n = 206) | Formoterol 9 μg bid (n = 199) |
|---|---|---|---|
Nasopharyngitis | 20 (9.6) | 24 (11.7) | 25 (12.6) |
COPD exacerbation | 17 (8.2) | 10 (4.9) | 8 (4.0) |
Bronchitis complication | 2 (1.0) | 1 (0.5) | 7 (3.5) |
Pneumonia | 0 | 2 (1.0) | 3 (1.5) |
Ill-defined disorder | 2 (1.0) | 2 (1.0) | 1 (0.5) |
Back pain | 3 (1.4) | 0 | 1 (0.5) |
Dizziness | 1 (0.5) | 2 (1.0) | 1 (0.5) |
Glucose present in urine | 2 (1.0) | 2 (1.0) | 0 |